· Periodic Report
Q3 operating loss of KRW 16.3 billion, larger than a year earlier
Olix sold KRW 2.2 billion in Q3 and lost KRW 16.3 billion from its main business, versus sales of KRW 2.9 billion and a KRW 8.3 billion loss a year earlier.
226950 · KOSDAQ · Based on DART filings
1 total · 20 per page
· Periodic Report
Olix sold KRW 2.2 billion in Q3 and lost KRW 16.3 billion from its main business, versus sales of KRW 2.9 billion and a KRW 8.3 billion loss a year earlier.
Get app alerts for new disclosures from OliX Pharmaceuticals, Inc..